Type‑oriented Glycine segmentation distinguishes four chemical families that shape production volume and pricing dynamics. Pure L‑α‑glycine is the baseline crystalline amino acid, comprising roughly 55 % of global output; its low‑cost synthesis and wide‑range applicability make it the default choice for most formulations. Glycine hydrochloride, representing about 20 % of the market, introduces a salt form that enhances solubility and stability in aqueous systems, a critical attribute for injectable drugs and high‑purity food additives. Glycine betaine, accounting for roughly 15 % of sales, is a zwitterionic derivative employed chiefly as an osmoprotectant in animal feed and stress‑mitigation agents for crops; its premium price reflects additional processing steps. The remaining 10 % consists of specialty derivatives such as N‑acetylglycine, glycine‑ethyl‑ester, and polymer‑bound glycine, which target niche applications in cosmetics, biodegradable plastics, and advanced therapeutics. By quantifying each type’s share, the market taxonomy clarifies how product differentiation influences overall Glycine market size. These proportions also guide capacity planning for manufacturers, as shifts toward higher‑value derivatives can elevate average selling prices across the sector.